Pilot Trial: Bioavailability Animal vs. Plant Protein Drink
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorETH Zurich
About this trial
A pilot study is being conducted to compare a new plant-based protein drink to commercially available animal-based protein drinks. The goal is to assess if the plant-based drink delivers amino acids to the bloodstream as effectively as the animal-based drinks, potentially offering a viable option for those on plant-based diets.
The study will involve approximately 12 healthy adults aged 18-40. Each participant will try all three drinks (the new plant-based drink, a commercial animal-based drink, and another animal-based recipe) on separate days in a randomized order. Before and after (30, 60, and 90 minutes) consuming each drink, a small blood sample will be drawn to measure amino acid levels (leucine).
By comparing the results, the investigators hope to determine if the plant-based drink can match the effectiveness of animal-based protein drinks in delivering essential nutrients. This research could contribute to the development of sustainable and nutritious plant-based protein alternatives.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Gender: male and female
Age: 18-40 years
Signed written informed consent
Disqualifiers
Smoking history
Cardiovascular diseases
BMI > 35 kg/m2
Caffeine consumption < 1 day before the study participation
Trial design
Design model
Crossover
Treatments tested in this trial
Consumption of protein - rich drink
Dietary supplementThe participants will drink on of three protein - rich drinks
Treatment groups
12 Participants
are divided into 3 treatment groupsGroup A: Animal-based AActive comparator 1 intervention
Group B: Animal-based BActive comparator 1 intervention
Group C: Plant-based AActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
leucine content in the blood
Assessment of leucine content in blood before and 30-60-90 min after consumption of drink
Time frame
4 hours Source ClinicalTrials.gov